|Cash flow from operations||$1.5 billion|
|GAAP EPS||$0.35||984 million shares|
|Non-GAAP EPS||$1.31||1,044 million shares|
Will investors want to wait 12 to 18 months to see Allergan's deals pay dividends?
As the broader markets surge, these three stocks are falling. Are any of them value plays?